Lawsuit: Medicaid Patients Often Wait For Hepatitis C Meds

Mar 21, 2016

Drugs that treat Hepatitis C are expensive, but limited Medicaid funds restrict patient access to treatment until late stages of Hep C.
Credit Stan Jastrzebski / WBAA News

More than 3 million people in United States are infected with Hepatitis C, a virus that can destroy the liver and cause liver cancer. 

The number of cases is increasing, according to the Centers for Disease Control and Prevention, and most new cases are attributed to injection drug abuse.

In the last few years, new drugs have come on the market that can cure hepatitis C with a more than 90 percent success rate.

But as Side Effects Public Media’s Jake Harper reports, for some people on Medicaid, actually getting that cure can be difficult.